So far Edge Trial Assurance has been used in 30 trials. It has detected 50-75 data anomalies in every single trial.
Genomic data is being integrated into clinical trials—sometimes not so successfully, and sometimes very, very successfully.
The topic of Brexit tends to generate more questions than answers.
When it comes to submitting new drug applications to FDA, it’s safe to assume that the prospect of receiving a complete response letter keeps pharma executives up at night. The risks associated with regulatory submission can have a substantial impact on a business, and approval delays due to data issues can cost a company millions.
As a former FDA reviewer, I’ve seen just about everything when it comes to data quality issues that can derail drug approvals. Luckily, today these kinds of risks can be mitigated using sophisticated data analytics.
Ingesting, integrating, standardizing, cleaning, coding, and analyzing disparate data sources creates complexity.